During the past decade, CAP Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CAP Research" are "Lupus Erythematosus, Systemic" (2 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "CAP Research" in a lesser frequency.

Most popular intervention types in "CAP Research" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "IPP-201101" (2 trials), "Placebo" (2 trials), "ILT-101" (1 trials) and "Standard of Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "CAP Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "CAP Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in CAP Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CAP Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".